Warrant
Issued 2024
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: ILExchange: Nasdaq
DilutionScan read 24 of XTL BIOPHARMACEUTICALS LTD's SEC filings and found 6 warrant series, 1 convertible and 2 completed offerings on file for XTLB. The latest dilution event on file is a warrant issuance on Jun 30, 2026. Analysis updated Oct 5, 2026.
Raise routes on file: no active ATM, effective shelf, S-1 or equity line in the filings read · latest dilution event 127 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Jun 30, 2026 · Warrant Issuance
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2024
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Principal
Conversion Price
Gross proceeds
Price per share
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z